Popular Diabetes Rx May Not Cut Bladder Cancer Risk
Widely given to patients with type 2 diabetes, metformin has been linked to reducing the risk for many types of cancers. The medication, however, may not be effective against one certain cancer.
Diabetes Medications May Impact Cancer Risks
People with type 2 diabetes have higher cancer risks than the general population. The link may have to do with how diabetes affects the metabolism. Diabetes medications may also figure into the equation.
Trends in Treating Diabetes
Diabetes is a big problem in the US — and thus, it is a big focus of doctors, researchers and pharmaceutical companies alike. New medications and developments alter how diabetes is treated.
New Diabetes Rx Delivers Results
While several medications are already on the market to treat diabetes, not all patients have the desired control over their blood sugar levels. Alogliptin may offer a fresh option.
Generic Actos to Treat Type 2 Diabetes
The U.S. Food and Drug Administration (FDA) today approved the first generic version of Actos ( pioglitazone hydrochloride) tablets. Along with diet and exercise, pioglitazone is used to improve blood glucose control in adults with type 2 diabetes.
Byetta Approved for Use With Basal Insulin
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company BYETTA ( exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos ( pioglitazone ), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Turning Around Type 2
Type 2 diabetes may be the most common form, affecting millions of Americans. That doesn't mean it has to be a chronic condition. A healthy lifestyle can help you turn around the disease and live free of medication.
The Decade in Diabetes
Treatments for type 2 diabetes are not what they used to be… they are even better! Throughout the past decade, new drugs and other tools have made it easier for patients to live with the disease.
New Guidance on Actos or Takeda
If you've been taking Actos or Takeda for more than a year to control your type 2 diabetes, you will want to be in touch with your family physician or endocrinologist. A link with bladder cancer has been discovered.
Sales of Diabetes Drugs Stopped Due to Bladder Cancer Risks
Actos and Competact, two top-selling type 2 diabetes drugs, have been pulled off the markets in France and Germany following studies linking the medications to bladder cancer.